<DOC>
	<DOCNO>NCT00119483</DOCNO>
	<brief_summary>Male hypogonadism clinical situation characterize low serum testosterone level combination diversity symptom sign reduce libido vitality , decreased muscle mass , increase fat mass depression . Similar symptom combination subnormal testosterone level see elderly men . Low testosterone level associate know cardiovascular risk factor , men diabetes stroke low testosterone level healthy men . Even though several publication suggest testosterone treatment hypogonadal men may beneficial effect , still uncertain testosterone substitution age man indicate . Despite uncertainty sale testosterone increase enormously last year . We hypothesize old men subnormal testosterone level vary degree dysfunction/symptoms physically mentally , dysfunction/symptoms improve testosterone treatment .</brief_summary>
	<brief_title>Older Men Testosterone</brief_title>
	<detailed_description>Older men testosterone ( Short version study protocol ) Cohort study `` How life elderly man serum testosterone subnormal ? '' To investigate whether subnormal testosterone level elderly men ( 60-80 year old ) associate clinical symptom and/or disease , investigator ask men normal testosterone ( &gt; 11.3 nmol/l ) men subnormal testosterone level ( &lt; 11.3 nmol/l ) participate last Tromsø study 2001 participate study . Screening : Blood pressure , clinical examination include prostate examination , blood sample ( testosterone , SHBG , LH , FSH , albumin PSA ) . Aproximately 350 men subnormal testosterone level last Tromsø study researcher try include 200 men still subnormal testosterone level 200 age match men still normal testosterone level . Procedures Symptoms : Aging Male Symptom Score Muscle strength function : The researcher investigate muscle strength , peak torque isokinetic dynamometry knee joint muscle function ( gait , balance movement ) ; Grip Strength Neuropsychological test - Cognitive function level : WAIS - Memory : Wechslers Memory Scale Revised ( WMS-R ) - Trail make A B . - Attention concentration : Knox cube - Cognitive flexibility : Word fluency test Stroop test - Quality life : GHQ - 30 Likert score - Depression : Beck Depression Inventory The metabolic syndrome - DEXA ( Lunar Prodigy ) : *Whole body , body composition ; *Lumbar spine hip , bone mineral density - CT scan abdomen distinguish intra vs. subcutaneous fat deposit . - Oral glucose tolerance test . - Lipid profile /per oral fat load . ( 80 men take part investigation ) - Examination androgen receptor , especially CAG GGN polymorphism androgen receptor associate glucose fat metabolism . - Blood pressure heart rate . - Neuroendocrine regulation : LH , FSH , SHBG , estradiol , testosterone , cortisol , ACTH , IGF-1 , IGFBP-3 , TSH , FT4 , prolactin leptin . - Sleep Interventions study `` Should subnormal testosterone level treat ? '' To investigate whether old men subnormal testosterone level would benefit physiological testosterone supplementation , men subnormal testosterone level participate cohort study ( approximately 150-200 men ) ask participate one year intervention study . Randomization treatment : Double blind randomize ( 1:1 ) 1-year study . First injection inclusion , second 6 week , third injection 16 week , fourth 28 week last 40 week . Active treatment Nebido , 1000 mg testosteron undecanoate , 4 ml intramuscular depot injection . Schering AS supply study Nebido placebo ( contain `` castor oil '' `` benzyl benzoate '' ) . Registration adverse event : All adverse event record participant CRF . Serious adverse event report accord regulation . Procedures : The above-described procedure cohort study also perform intervention study . Testosterone level , hematocrit , creatinine , ALAT PSA control every visit . Object variable cohort intervention study Primary : Psychosexual quality life ; Muscle strength Secondary : Muscle function ; Body composition ; Intraabdominal vs. subcutaneous fat distribution ; CAG GGN polymorphism androgen receptor gene ; Bone mineral density ; Per oral glucose tolerance test ; Lipid profile/fat tolerance test ; Neuropsychological test ; Neuroendocrine regulation Sleep Statistics method : The study perform Clinical research ward University Hospital North Norway . Comparisons group assess non-parametrical test ( Mann-Whitney U-test ) ANOVA significant level p &lt; 0.05 . In intervention study delta-values use assess change treatment difference study group . SPSS use statistical program . Inclusion patient cohort study complete 2006 intervention study complete 2007 . Research partner Johan Svartberg , Department Medicine , University Hospital North Norway , Tromsø , Norway responsible investigator . Partners : Professor Rolf Jorde John-Bjarne Hansen MD , PhD , Department Medicine , Professor Johan Sundsfjord , Department Clinical Chemistry Professor Knut Waterloo , Department Neurology , University Hospital North Norway , Tromsø , Norway Professor Aleksander Giwercman , Scanian Andrology Center , Department Urology , Malmö University Hospital , Sweden .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Men 6080 year old Serumtestosterone level &lt; 11.0 nmol/l Signed informed consent . Prostate cancer Breast cancer Liver tumor/cancer Unstable angina Untreated congestive heart disease Epilepsy Migraine Hematocrit &gt; 50 % PSA &gt; 4.0 ug/l Serum creatinine &gt; 130 umol/l ALAT &gt; 100 U/l Known intolerance testosterone undecanoate Participation another research trial .</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Men</keyword>
	<keyword>testosterone</keyword>
	<keyword>hypogonadal</keyword>
	<keyword>age</keyword>
	<keyword>body composition</keyword>
	<keyword>quality og life</keyword>
	<keyword>Muscle strength</keyword>
	<keyword>Aging male</keyword>
</DOC>